TechLongevity Startup Doses First Human in Bid to Reverse Age-Associated Sight Lossnabeelhassan565@gmail.comJune 9, 2026 by nabeelhassan565@gmail.comJune 9, 2026015 A long life startup has dosed its first affected person with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug,...